The MEF2A and MEF2D function as scaffold proteins that interact with HDAC1 or p300 in SOD3 expression in THP-1 cells

Free Radical Research
Mari IchiharaTetsuo Adachi

Abstract

Superoxide dismutase 3 (SOD3) is a SOD isozyme and plays a key role in extracellular redox homeostasis. We previously demonstrated that histone acetylation is involved in 12-O-tetra-decanoylphorbol-13-acetate (TPA)-elicited SOD3 expression in human monocytic THP-1 cells; however, the molecular mechanisms responsible for its expression have not yet been elucidated in detail. The results of the present study demonstrated that the binding of histone deacetylase 1 (HDAC1) to the SOD3 promoter region contributed to SOD3 silencing in basal THP-1 cells. On the other hand, the dissociation of HDAC1 from the SOD3 promoter region and the enrichment of p300, a histone acetyltransferase (HAT), within that region were observed in TPA-induced THP-1 cells. Myocyte enhancer factor 2 (MEF2) functions as a scaffold protein that interacts with histone deacetylases (HDAC) or HAT and regulates gene expression. The present results showed that the MEF2A and MEF2D function as mediators for TPA-elicited SOD3 expression by interacting with HDAC or p300. Additionally, the knockdown of MEF2A or MEF2D in human skin fibroblasts suppressed SOD3 expression at the mRNA and protein levels. Our results provide an insight into epigenetic regulation of redox gene ...Continue Reading

References

Feb 15, 1990·The Biochemical Journal·S L Marklund
Dec 1, 1982·Proceedings of the National Academy of Sciences of the United States of America·S L Marklund
Sep 1, 1994·The European Respiratory Journal·I VachierP Godard
Jan 1, 1996·Molecular and Cellular Biology·J W Fickett
Sep 3, 1996·Proceedings of the National Academy of Sciences of the United States of America·J D Molkentin, E N Olson
Mar 1, 1997·Experimental Physiology·H Sies
Jun 22, 1999·Nucleic Acids Research·O I OrnatskyJ C McDermott
Mar 29, 2000·Proceedings of the National Academy of Sciences of the United States of America·J LuE N Olson
Apr 5, 2000·The Journal of Biological Chemistry·C LemercierS Khochbin
Mar 30, 2001·The Journal of Biological Chemistry·U DresselG E Muscat
Oct 5, 2001·The Journal of Biological Chemistry·H Y KaoS Khochbin
May 29, 2004·Arteriosclerosis, Thrombosis, and Vascular Biology·Frank M Faraci, Sean P Didion
Feb 24, 2006·International Journal of Clinical Practice·E WrightL C Glass
Apr 20, 2006·Clinical and Experimental Pharmacology & Physiology·Sean L McGee, Mark Hargreaves
Dec 13, 2006·Molecular and Cellular Biology·Serge GrégoireXiang-Jiao Yang
Oct 26, 2007·Development·Matthew J Potthoff, Eric N Olson
May 28, 2009·Journal of the American Society of Nephrology : JASN·Hiroki FujitaTakamune Takahashi
Jul 2, 2010·The Biochemical Journal·Catherine Aude-GarciaClaudie Lemercier
Nov 16, 2010·Journal of Cellular Biochemistry·Tetsuro KamiyaTetsuo Adachi
Dec 14, 2012·American Journal of Physiology. Renal Physiology·Hang YuanRama Natarajan
Apr 23, 2013·Free Radical Biology & Medicine·Tetsuro KamiyaTetsuo Adachi
Jan 31, 2015·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Brianne R O'LearyJames J Mezhir
Nov 30, 2016·Journal of Clinical Biochemistry and Nutrition·Hiroyuki YasudaTetsuo Adachi
Jun 7, 2017·Journal of Clinical Biochemistry and Nutrition·Shunpei MorisawaTetsuo Adachi
Jul 29, 2017·Journal of Clinical Biochemistry and Nutrition·Atsuko OhashiTetsuo Adachi

❮ Previous
Next ❯

Citations

May 21, 2019·Oncotarget·Kiran MadugulaPooja Jain
Apr 2, 2020·Journal of Clinical Biochemistry and Nutrition·Ryuhei TakemotoTetsuo Adachi
Sep 3, 2019·Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan·Tetsuro Kamiya
Mar 2, 2021·Journal of Cellular Biochemistry·Ryuhei TakemotoTetsuo Adachi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.

Cancer Epigenetics and Senescence (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may be involved in regulating senescence in cancer cells. This feed captures the latest research on cancer epigenetics and senescence.

Related Papers

Biometals : an International Journal on the Role of Metal Ions in Biology, Biochemistry, and Medicine
Tetsuro KamiyaTetsuo Adachi
© 2022 Meta ULC. All rights reserved